American CryoStem Launches New Consumer Website Design
RED BANK, NJ–(Marketwire – Jan 19, 2012) – American CryoStem Corporation (OTCQB: CRYO) announced today the launch of the Company’s redesigned website americancryostem.com. The new website is a sophisticated online destination showcasing the Company’s branding and marketing of its core “Collect Process and Store” consumer stem cell service.
The new website experience is centered on providing the consumer simple, easy to read information about Adult Stem Cells and CRYO’s long term adult stem cell storage service currently offered through a national network of physicians. “The decision to redesign the website to be more consumer friendly was an easy decision after CRYO’s successful media campaign launch that attracted over 11,000 new members. From the feedback we received, we knew it was time for an update,” explains Natalia Drulle, Creative Director.
As part of CRYO’s on-going marketing campaign the new site features a live chat function to answer questions concerning the Company’s products and services. “Adding this dynamic feature to the site experience is a useful tool to increase customer support and sales conversion,” says John DiFolco, Director of Marketing. “Our goal is to shorten the sales process and provide instant support as we participate in the Regenerative Medicine market where Adult Stem Cells are frequently the main focus of discussion.”
John Arnone, CEO, stated, “The launch of our new website is another step in offering our products and services directly to the consumer market. Having the ability to educate our clients and then refer them to participating physicians allows us to efficiently deliver our message to targeted areas of the country where our service is being adopted.”
About American CryoStem: The Company markets a core clinical processing platform for Adipose (fat) Derived Adult Stem Cells. The Company’s services provide for the collection, processing, and cryopreservation (long term storage) of adult stem cells, allowing healthy individuals to privately preserve their stem cells for future use in personalized and regenerative medicine at an affordable price. Adult Stem Cells treatments are currently being utilized to potentially heal one’s own body of diseases and chronic conditions. The Company’s proprietary platform provides streamlined and affordable processing and cryopreservation of Adipose Derived Stem Cells (ADSCs) and Adipose Tissue (AT) for autologous use.
